MDD

News

J&J seeks to rewrite the script on depression treatment

A survey has found that most patients with depression have little hope of being free of their symptoms, and Johnson & Johnson aims to change that.

R&D

an old woman and her middle-aged daughter image for a feature on ageing and neurological conditions

Ageing Europe - It’s time we prioritised neurological condit...

Europeans are living longer than ever before – tangible proof of the phenomenal advancements in science and healthcare.1,2 However, it comes with a paradoxical rise in nervous sy

News

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks